No takes yet. Share an insight, caveat, or question.
Randomized trial reveals SB 203580 inhibits reactivating kinase activation and HSP27 phosphorylation in vivo, suggesting its potential for further physiological studies.
Cuenda et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: